Efficacy of soybean-based vaccines using a model antigen
Efficacy of soybean-based vaccines using a model antigen
批准号:
7093490
负责人:
KENNETH J PILLER
金额:
$26.42万
依托单位国家:
美国
项目类别:
财政年份:
2005
资助国家:
美国
项目状态:
已结题
起止时间:
2005-07-15 至 2008-06-30
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Vaccines that stimulate mucosal immune responses of the gastrointestinal tract would be advantageous since such formulations would provide immunity at the site of pathogen entry. Edible vaccines have received much attention since, in theory, they represent a source of vaccine that would stimulate immune responses of the gastrointestinal tract, be cost-effective to produce, safe to administer, and a highly stable form for shipment throughout the world. Unfortunately, there are many practical problems that remain when trying to reduce such potential into reality. Studies to be conducted here will directly address some of the most important challenges that face this technology for developing edible subunit vaccines in soybeans which could be applied to the formulation of novel human gastrointestinal vaccines. We propose the use of a model antigen, E. coli FanC, so that definitive questions can be addressed regarding the protective nature of the humoral and cell mediated gastrointestinal response induced when this edible vaccine is coupled with an oral adjuvant.
Expression of the model antigen, E. coli FanC, in transgenic soybeans will be used to provide practical information regarding the utility of edible subunit vaccines. Following oral immunization with FanC expressed in transgenic soybeans coupled with an oral adjuvant, the humoral and cellular immune response will be defined at mucosal and systemic sites. In addition, the ability of this vaccine formulation to protect mice against a challenge with enterotoxigenic E. coli will also be determined. Finally, novel formulations of this edible vaccine will be investigated for their potential to stimulate gastrointestinal immunity. Despite the promise of plant based vaccines as a low cost method for stimulating gastrointestinal immunity, significant questions still remain about the feasibility of developing such methods for immunizing humans. The present proposal focuses on the practicality of using edible subunit vaccines for oral immunization.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Oral autoantigen therapy for the treatment of Multiple Sclerosis
-
批准号:10157209
-
项目类别:
-
资助金额:$28.86万
-
财政年份:2021
-
负责人:KENNETH J PILLER
-
依托单位:
Oral autoantigen therapy for the treatment of Multiple Sclerosis
-
批准号:10331867
-
项目类别:
-
资助金额:$29.5万
-
财政年份:2021
-
负责人:KENNETH J PILLER
-
依托单位:
Platform for practical delivery of oral autoantigens as co-therapies for neurological disease
-
批准号:9341398
-
项目类别:
-
资助金额:$49.57万
-
财政年份:2016
-
负责人:KENNETH J PILLER
-
依托单位:
Improved diagnostic and monitoring assays for thyroid cancer
-
批准号:7907500
-
项目类别:
-
资助金额:$21.62万
-
财政年份:2010
-
负责人:KENNETH J PILLER
-
依托单位:
Improved diagnostic and monitoring assays for thyroid cancer
-
批准号:8591270
-
项目类别:
-
资助金额:$39.16万
-
财政年份:2010
-
负责人:KENNETH J PILLER
-
依托单位:
Improved diagnostic and monitoring assays for thyroid cancer
-
批准号:8885710
-
项目类别:
-
资助金额:$39.35万
-
财政年份:2010
-
负责人:KENNETH J PILLER
-
依托单位:
Improved diagnostic and monitoring assays for thyroid cancer
-
批准号:8692671
-
项目类别:
-
资助金额:$39.02万
-
财政年份:2010
-
负责人:KENNETH J PILLER
-
依托单位:
Novel therapy for treating Multiple Sclerosis
-
批准号:7668842
-
项目类别:
-
资助金额:$23.97万
-
财政年份:2009
-
负责人:KENNETH J PILLER
-
依托单位:
A Novel Therapy for Staphyloccocal Enterotoxin B poisoning
-
批准号:7271825
-
项目类别:
-
资助金额:$20.1万
-
财政年份:2007
-
负责人:KENNETH J PILLER
-
依托单位:
Efficacy of soybean-based vaccines using a model antigen
-
批准号:7256444
-
项目类别:
-
资助金额:$25.27万
-
财政年份:2005
-
负责人:KENNETH J PILLER
-
依托单位:
Efficacy of soybean-based vaccines using a model antigen
-
批准号:6926625
-
项目类别:
-
资助金额:$28.93万
-
财政年份:2005
-
负责人:KENNETH J PILLER
-
依托单位:
海外基金